Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1950 of 3173 entries
View as:

A Study To Compare The Amount Of Tasocitinib (CP-690,550) That Is Absorbed Into The Blood Of Healthy Subjects Following Oral Administration Of Three Different Tablet Versions Of Tasocitinib (CP-690,550)

Phase: N/A Priority: Normal
NCT ID: NCT01184092 Org: User:
Start: 08/31/10 End: 09/30/10 Due: 09/30/11

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Doses of PF-06852231 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03217604 Org: User:
Start: 07/13/17 End: 02/01/18 Due: 02/01/19

Safety, Pharmacokinetics (PK) and Tolerability Study of a Novel Drug for Treatment of Bacterial Infections

Phase: N/A Priority: Normal
NCT ID: NCT01015014 Org: User:
Start: 11/05/09 End: 05/13/10 Due: 05/13/11

A Study to Investigate the Effects of PF00610335 on the QT/QTC Interval in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01107054 Org: User:
Start: 06/30/10 End: 12/31/10 Due: 12/31/11

ARCHER1050: A Study of Dacomitinib vs. Gefitinib in 1st-Line Treatment Of Advanced NSCLC.

Phase: N/A Priority: Normal
NCT ID: NCT01774721 Org: User:
Start: 05/09/13 End: 01/27/22 Due: 01/27/23

A Multiple Dose Study of PF-04950615 (RN316) in Subjects on High Doses of Statins

Phase: N/A Priority: Normal
NCT ID: NCT01342211 Org: User:
Start: 07/31/11 End: 06/30/12 Due: 06/30/13

Avelumab in Previously Untreated Patients With Epithelial Ovarian Cancer (JAVELIN OVARIAN 100)

Phase: N/A Priority: Normal
NCT ID: NCT02718417 Org: User:
Start: 05/19/16 End: 05/16/19 Due: 05/16/20

Drug Use Investigation for Toviaz

Phase: N/A Priority: Normal
NCT ID: NCT01936870 Org: User:
Start: 10/01/13 End: 05/19/16 Due: 05/19/17

Post Marketing Surveillance Study To Observe Safety And Efficacy Of Aromasin In The Patients With Early Or Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01047358 Org: User:
Start: 06/30/10 End: 06/30/14 Due: 06/30/15

Effects of ICA-105665 Using the Intradermal Capsaicin and Ultraviolet B (UV-B) Models in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00962663 Org: User:
Start: 08/31/09 End: 12/31/09 Due: 12/31/10

A Study to Learn About the Effects of Sisunatovir in Infants With Respiratory Syncytial Virus Lower Respiratory Tract Infection.

Phase: N/A Priority: Normal
NCT ID: NCT04225897 Org: User:
Start: 11/13/19 End: 12/05/22 Due: 12/05/23

Extension Study Of Subjects From Study A3921030 For The Prevention Of Acute Rejection In Kidney Transplant Patients

Phase: N/A Priority: Normal
NCT ID: NCT00658359 Org: User:
Start: 08/31/08 End: 06/30/15 Due: 06/30/16

Treatment With Recombinant Human Growth Hormone (GH) in Children With Short Stature Secondary to a Long Term Corticoid Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00174187 Org: User:
Start: 09/30/00 End: 09/30/11 Due: 09/30/12

Efficacy and Safety of Ceftazidime-Avibactam (CAZ-AVI) in Chinese Participants With HAP (Including VAP)

Phase: N/A Priority: Normal
NCT ID: NCT04774094 Org: User:
Start: 05/21/21 End: 05/04/23 Due: 05/04/24

Study of Single and Multiple Ascending Doses of PF-07059013 in Healthy Adult Participants

Phase: N/A Priority: Normal
NCT ID: NCT04323124 Org: User:
Start: 07/17/20 End: 10/21/21 Due: 10/21/22

A Study to Compare Two Different Forms of PF-07081532 in Adults Who Are Overweight or Obese

Phase: N/A Priority: Normal
NCT ID: NCT05677867 Org: User:
Start: 01/18/23 End: 03/14/23 Due: 03/14/24

Ventilator-Associated Pneumonia/Hospital-Acquired Pneumonia Requiring Mechanical Ventilatory Support

Phase: N/A Priority: Normal
NCT ID: NCT00050401 Org: User:
Start: 07/31/02 End: 09/30/04 Due: 09/30/05

Effect Of PF-06305591 On Capsaicin And Capsaicin/Heat-Induced Neurogenic Flare

Phase: N/A Priority: Normal
NCT ID: NCT01797796 Org: User:
Start: 04/30/13 End: 07/31/13 Due: 07/31/14

Study To Evaluate The Effect Of Single Intravenous Doses Of Tigecycline On QTc Intervals In Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01287793 Org: User:
Start: 01/31/11 End: 05/31/11 Due: 05/31/12

Bioavailability Study of Naloxone 5 Milligrams (mg) Intramuscular (IM) Autoinjector

Phase: N/A Priority: Normal
NCT ID: NCT05264493 Org: User:
Start: 10/06/20 End: 01/08/21 Due: 01/08/22

A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)

Phase: N/A Priority: Normal
NCT ID: NCT06991257 Org: User:
Start: 06/05/25 End: 11/30/27 Due: 11/30/28

Patient's Management Receiving Eplerenone Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01440049 Org: User:
Start: 09/30/08 End: 12/31/10 Due: 12/31/11

Single-dose Study of [14C]Lorlatinib (PF-06463922) Metabolism In Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT03184168 Org: User:
Start: 07/05/17 End: 08/25/17 Due: 08/25/18

A Global Phase 3 Safety Study of 120 mcg rLP2086 Vaccine in Adolescents and Young Adults Aged 10 to 25 Years

Phase: N/A Priority: Normal
NCT ID: NCT01352793 Org: User:
Start: 11/30/12 End: 09/30/14 Due: 09/30/15

Comparison Of 5 CP-690,550 Doses Vs. Placebo, For The Treatment Of Rheumatoid Arthritis In Japan

Phase: N/A Priority: Normal
NCT ID: NCT00687193 Org: User:
Start: 03/31/09 End: 07/31/10 Due: 07/31/11